Roles of extrahepatic lipolysis and the disturbance of hepatic fatty acid metabolism in TNF-α -induced hepatic steatosis

Toxicology ◽  
2019 ◽  
Vol 411 ◽  
pp. 172-180 ◽  
Author(s):  
Rui Yang ◽  
Min-Jie Guan ◽  
Ning Zhao ◽  
Ming-Jun Li ◽  
Tao Zeng
Biology ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 92
Author(s):  
Hao Xu ◽  
Yu Jiang ◽  
Xiao-Min Miao ◽  
Yi-Xi Tao ◽  
Lang Xie ◽  
...  

Hepatic steatosis caused by starvation, resulting in non-alcoholic fatty liver disease (NAFLD), has been a research topic of human clinical and animal experiments. To understand the molecular mechanisms underlying the triggering of abnormal liver metabolism by starvation, thus inducing hepatic lipid accumulation, we used zebrafish larvae to establish a starvation-induced hepatic steatosis model and conducted comparative transcriptome analysis by RNA-seq. We demonstrated that the incidence of larvae steatosis is positively correlated with starvation time. Under starvation conditions, the fatty acid transporter (slc27a2a and slc27a6-like) and fatty acid translocase (cd36) were up-regulated significantly to promote extrahepatic fatty acid uptake. Meanwhile, starvation inhibits the hepatic fatty acid metabolism pathway but activates the de novo lipogenesis pathway to a certain extent. More importantly, we detected that the expression of numerous apolipoprotein genes was downregulated and the secretion of very low density lipoprotein (VLDL) was inhibited significantly. These data suggest that starvation induces hepatic steatosis by promoting extrahepatic fatty acid uptake and lipogenesis, and inhibits hepatic fatty acid metabolism and lipid transport. Furthermore, we found that starvation-induced hepatic steatosis in zebrafish larvae can be rescued by targeting the knockout cd36 gene. In summary, these findings will help us understand the pathogenesis of starvation-induced NAFLD and provide important theoretical evidence that cd36 could serve as a potential target for the treatment of NAFLD.


2020 ◽  
Author(s):  
Ada Admin ◽  
Zhuo Mao ◽  
Mingji Feng ◽  
Zhuoran Li ◽  
Minsi Zhou ◽  
...  

ETV5 is an ETS transcription factor which has been associated with obesity in genomic association studies. However, little is known about the role of ETV5 in hepatic lipid metabolism and non-alcoholic fatty liver disease (NAFLD). In the present study, we found that ETV5 protein expression was increased in diet- and genetic-induced steatotic liver. ETV5 responded to the nutrient status in an mTORC1 dependent manner and in turn regulated mTORC1 activity. Both viral-mediated and genetic depletion of ETV5 in mice led to increased lipid accumulation in the liver. RNA sequencing analysis revealed that PPAR signaling and fatty acid degradation/metabolism pathways were significantly downregulated in ETV5 deficient hepatocytes <i>in vivo</i> and <i>in vitro. </i>Mechanistically, ETV5 could bind to the PPRE region of PPAR downstream genes and enhance its transactivity. Collectively, our study identifies ETV5 as a novel transcription factor for the regulation of hepatic fatty acid metabolism which is required for the optimal β oxidation process. ETV5 may provide a therapeutic target for the treatment of hepatic steatosis.<br>


2012 ◽  
Vol 52 (3) ◽  
pp. 1015-1027 ◽  
Author(s):  
Takashi Ide ◽  
Ayana Azechi ◽  
Sayaka Kitade ◽  
Yoko Kunimatsu ◽  
Natsuko Suzuki ◽  
...  

Obesity ◽  
2014 ◽  
Vol 22 (7) ◽  
pp. 1685-1693 ◽  
Author(s):  
Lisa M. Nicholas ◽  
Leewen Rattanatray ◽  
Janna L. Morrison ◽  
David O. Kleemann ◽  
Simon K. Walker ◽  
...  

1995 ◽  
Vol 227 (3) ◽  
pp. 715-722 ◽  
Author(s):  
Daniel K. Asiedu ◽  
Ayman Al-Shurbaji ◽  
Arild C. Rustan ◽  
Ingemar Bjorkhem ◽  
Lars Berglund ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document